Company
SwedenOctapharma AB, Stockholm, Sweden – FDA Inspections
Inspection records and compliance data for Octapharma AB in Stockholm. 7 FDA inspections on record (1 OAI), 3 Form 483s, last inspected September 19, 2023.
Company Profile
This profile covers Octapharma AB based in Stockholm, Sweden.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 1
- VAI
- 5
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 3
- Warning letters
- 0
First inspected January 29, 2009. Last inspected September 19, 2023.
Most cited issue areas
- Cleaning / Sanitizing / Maintenance1 inspection
- Procedure Deviations Recorded and Justified1 inspection
- Written in-process control procedures1 inspection
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 19, 2023 | VAI | Biologics · Blood and Blood Products | 1218250 |
| September 28, 2018 | VAI | Biologics · Blood and Blood Products | 1070173 |
| October 3, 2016 | Not classified | Biologics | 994537 |
| April 28, 2014 | VAI | Biologics · Blood and Blood Products | 894095 |
| January 19, 2012 | VAI | Biologics · Blood and Blood Products | 783783 |
| January 20, 2011 | OAI | Biologics · Blood and Blood Products | 710676 |
| January 29, 2009 | VAI | Biologics · Blood and Blood Products | 580664 |
FDA documents
Form 483s (1)
People (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
GlaxoSmithKline Vaccines Srl
AstraZeneca Pharmaceuticals LP
LifeSouth Community Blood Centers, Inc
Lonza Netherlands B.V.
Duke Medical Center-Carolinas Cord Blood Bank and Stem Cell Laboratory
Corixa Corporation
Kedrion S.p.A.
SmartPractice Denmark ApS
Kamada - Production Plant
Takeda Pharmaceutical Company Limited
Company Information
Name
Octapharma AB
FEI Number
3005559915
Address
Lars Forssells Gata 23, Stockholm, Sweden
Country
Sweden
ID: 5a456872-4ca6-4418-b006-6e7e219ec262